About Precigen, Inc. Common Stock
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
Market Cap
$0.47B
Employees
25
Listed Since
August 8, 2013
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.precigen.comPhone
301-556-9900
Headquarters
20374 SENECA MEADOWS PARKWAY
GERMANTOWN, MD 20876
CIK
0001356090